Research Topics
| S D HalpernSummaryAffiliation: University of Pennsylvania Country: USA Publications
| Collaborators
|
Detail Information
Publications
Who will enroll? Predicting participation in a phase II AIDS vaccine trialS D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pensylvania 19104 6021, USA
J Acquir Immune Defic Syndr 27:281-8. 2001..If prospective study subjects' stated willingness to participate (WTP) in hypothetical vaccine trials predicts future enrollment, then measuring WTP before recruitment may enhance the enrollment in, and ethics of, such trials...
Prospective preference assessment: a method to enhance the ethics and efficiency of randomized controlled trialsScott D Halpern
Center for Clinical Epidemiology and Biostatistics, Center for Bioethics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
Control Clin Trials 23:274-88. 2002..It is concluded that PPA is a feasible approach to a more democratic and efficient research process and that its adoption would be consistent with current trends in health care...
The continuing unethical conduct of underpowered clinical trialsScott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 108 Blockley Hall, 423 Guardian Dr, Philadelphia, PA 19104 6021, USA
JAMA 288:358-62. 2002..In both cases, investigators must inform prospective subjects that their participation may only indirectly contribute to future health care benefits...
Evaluating preference effects in partially unblinded, randomized clinical trialsScott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, 108 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104, USA
J Clin Epidemiol 56:109-15. 2003..It is concluded that investigators could use these methods to quantify potential preference effects in partially unblinded RCTs, and thereby more accurately estimate the specific effects of treatments...
Transplantation of kidneys from donors at increased risk for blood-borne viral infection: recipient outcomes and patterns of organ useP P Reese
Department of Medicine, Renal Division, Center for Clniical Epidemiology and Biostatistics and Leonard Davis Institute of Health Economics, University of Pennsylvania, Pennsylvania, PA, USA
Am J Transplant 9:2338-45. 2009..OPTN should collect detailed data about long-term outcomes and recipient viral testing so the potential risks of CDC kidneys can be fully evaluated...
Physicians' preferences for active-controlled versus placebo-controlled trials of new antihypertensive drugsScott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, USA
J Gen Intern Med 17:689-95. 2002..To evaluate physicians' preferences for referring patients to, and using information from, active-controlled trials (ACTs) versus placebo-controlled trials (PCTs) of new antihypertensive drugs...
Incentive models to increase living kidney donation: encouraging without coercingAjay K Israni
Department of Medicine, University of Pennsylvania, Philadelphia, PA, USA
Am J Transplant 5:15-20. 2005..We recommend the use of the expense reimbursement model along with these safeguards, in order to increase rates of living kidney donation...
HIV testing without consent in critically ill patientsScott D Halpern
Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia 19104-6021, USA
JAMA 294:734-7. 2005
Towards evidence based bioethicsScott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine; 115 Blockley Hall, 423 Guardian Drive, Philadelphia, PA 19104-6021, USA
BMJ 331:901-3. 2005
Decisions devoid of data?Scott D Halpern
School of Medicine, University of Pennsylvania, USA
Am J Bioeth 6:55-6; discussion W51-3. 2006
Evidence-based equipoise and research responsivenessScott D Halpern
Am J Bioeth 6:1-4. 2006
Terminal withdrawal of life-sustaining supplemental oxygenScott D Halpern
Division of Pulmonary, Allergy, and Critical Care Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia 19104-6021, USA
JAMA 296:1397-400. 2006
Development of an e-mail database of US intensive care physiciansScott D Halpern
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
J Crit Care 22:28-31. 2007..We sought to develop an e-mail database for all intensivists associated with US training programs in critical care medicine (academic intensivists) and to determine the feasibility of using this database to survey intensivists...
Harnessing the power of default options to improve health careScott D Halpern
Department of Medicine, The Leonard Davis Institute of Health Economics, the Center for Bioethics, University of Pennsylvania, Philadelphia 19104-6021, USA
N Engl J Med 357:1340-4. 2007
Nonconsented human immunodeficiency virus testing among critically ill patients: intensivists' practices and the influence of state lawsScott D Halpern
Division of Pulmonary, Allergy, and Critical Care Medicine, University of Pennsylvania, 423 Guardian Dr, 711 Blockley Hall, Philadelphia, PA 19104 6021, USA
Arch Intern Med 167:2323-8. 2007..Human immunodeficiency virus (HIV) testing can improve care for many critically ill patients, but state laws and institutional policies may impede such testing when patients cannot provide consent...
Informing candidates for solid-organ transplantation about donor risk factorsScott D Halpern
Pulmonary, Allergy, and Critical Care Division, University of Pennsylvania School of Medicine, Philadelphia, USA
N Engl J Med 358:2832-7. 2008
The ethics of randomized clinical trials in pulmonary arterial hypertensionScott D Halpern
Division of Pulmonary, Allergy and Critical Care Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
Proc Am Thorac Soc 5:631-5. 2008....
Determinants of transplant surgeons' willingness to provide organs to patients infected with HBV, HCV or HIVScott D Halpern
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, 19104 6021, USA
Am J Transplant 5:1319-25. 2005..HIV-infected patients should have equal access to organs unless or until evidence emerges that they fare substantially worse than other potential recipients...
Hypertensive patients' willingness to participate in placebo-controlled trials: implications for recruitment efficiencyScott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
Am Heart J 146:985-92. 2003....
Commentary: Improving response rates to mailed surveys: what do we learn from randomized controlled trials?Scott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA
Int J Epidemiol 32:637-8. 2003
Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysisAjay K Israni
Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
Kidney Int 65:990-8. 2004..However, there is concern that difficulties recruiting patients may prevent the successful completion of such trials if patients believe the inconveniences of daily dialysis outweigh any potential health benefits...
Preevent vaccination against smallpox: a survey of pediatric emergency health care providersWorth W Everett
Department of Emergency Medicine, Hospital of the University of Pennsylvania, Centers for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, PA, USA
Pediatr Infect Dis J 23:332-7. 2004..A greater understanding of the knowledge, attitudes and beliefs of pediatric health care workers toward preevent smallpox vaccination will assist in the development of future bioterrorism preparedness programs...
Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trialsScott D Halpern
Department of Medicine, Centers for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, USA
Arch Intern Med 164:801-3. 2004..Paying patients to participate in clinical trials is ethically controversial. However, there has been no empirical documentation regarding whether payment represents an undue or unjust inducement...
Willingness of patients to switch from conventional to daily hemodialysis: looking before we leapScott D Halpern
Department of Medicine, University of Pennsylvania, Philadelphia, USA
Am J Med 116:606-12. 2004....
Solid-organ transplantation in HIV-infected patientsScott D Halpern
University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
N Engl J Med 347:284-7. 2002
Smallpox vaccination: a national survey of emergency health care providersWorth W Everett
Department of Emergency Medicine, Hospital of the University of Pennsylvania, Philadelphia 19104, USA
Acad Emerg Med 10:606-11. 2003..Although emergency health care providers are among the first targeted for vaccination, little is known about how these providers view the risks and benefits of SP vaccination...
Reporting enrollment in clinical trialsScott D Halpern
Ann Intern Med 137:1007-8; author reply 1007-8. 2002
Research recruitment via camouflaged sampling: addressing the legal and ethical aspects of privacy concernsHilary M Wandall
Merck and Co, Inc, NJ, USA
Pharmacoepidemiol Drug Saf 17:798-800. 2008
Randomized trial of 5 dollars versus 10 dollars monetary incentives, envelope size, and candy to increase physician response rates to mailed questionnairesScott D Halpern
Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania, Philadelphia, Pennsylvania, USA
Med Care 40:834-9. 2002..Including smaller incentives in more questionnaires may maximize total responses...
Response to Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trialScott D Halpern
J Acquir Immune Defic Syndr 33:412. 2003
Re-examining ethical obligations in the intensive care unit: HIV disclosure to surrogatesAnthony T Vernillo
New York University College of Dentistry, Department of Oral and Maxillofacial Pathology, Radiology and Medicine, New York, New York 10010, USA
Crit Care 11:125. 2007..We also provide a tabulation of individual US state laws relevant to disclosure of HIV status...
Post-call accidentsScott D Halpern
N Engl J Med 352:1491-2; author reply 1491-2. 2005
Inadequate hepatitis B vaccination and post-exposure evaluation among transplant surgeons: prevalence, correlates, and implicationsScott D Halpern
Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-6021, USA
Ann Surg 244:305-9. 2006..Requiring documentation of HBV vaccination and immunity to maintain operating room privileges may protect surgeons, their patients, and operating room staff...
Epidemiologic studies of adverse effects of anti-retroviral drugs: how well is statistical power reportedScott D Halpern
Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
Pharmacoepidemiol Drug Saf 14:155-61. 2005..Future research is needed to determine whether the observed paucity of industry-sponsored observational studies of anti-retroviral ADEs extends to other clinical areas, and if so, to identify the causes of this phenomenon...
Re: "Ethics and sample size"Scott D Halpern
Am J Epidemiol 162:195-6; author reply 196. 2005
